Current research on DAPK1 mainly focuses on cancers (Movahhed et al., 2022), Alzheimer’s disease (Chen et al., 2020; Qi et al., 2020; Wang et al., 2021), stroke (Wang et al., 2017), Parkinson’s disease (Dachsel et al., 2011) and epilepsy (Gan et al., 2021). This evidence concerns the gene DAPK1 and Parkinson disease.